1. Home
  2. GGT vs STXS Comparison

GGT vs STXS Comparison

Compare GGT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GGT
  • STXS
  • Stock Information
  • Founded
  • GGT 1994
  • STXS 1990
  • Country
  • GGT United States
  • STXS United States
  • Employees
  • GGT N/A
  • STXS N/A
  • Industry
  • GGT Trusts Except Educational Religious and Charitable
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GGT Finance
  • STXS Health Care
  • Exchange
  • GGT Nasdaq
  • STXS Nasdaq
  • Market Cap
  • GGT 128.7M
  • STXS 151.3M
  • IPO Year
  • GGT N/A
  • STXS 2004
  • Fundamental
  • Price
  • GGT $4.28
  • STXS $2.14
  • Analyst Decision
  • GGT
  • STXS
  • Analyst Count
  • GGT 0
  • STXS 0
  • Target Price
  • GGT N/A
  • STXS N/A
  • AVG Volume (30 Days)
  • GGT 59.7K
  • STXS 282.8K
  • Earning Date
  • GGT 01-01-0001
  • STXS 05-12-2025
  • Dividend Yield
  • GGT 15.56%
  • STXS N/A
  • EPS Growth
  • GGT N/A
  • STXS N/A
  • EPS
  • GGT 0.83
  • STXS N/A
  • Revenue
  • GGT N/A
  • STXS $26,918,000.00
  • Revenue This Year
  • GGT N/A
  • STXS $25.90
  • Revenue Next Year
  • GGT N/A
  • STXS $60.57
  • P/E Ratio
  • GGT $6.90
  • STXS N/A
  • Revenue Growth
  • GGT N/A
  • STXS 0.55
  • 52 Week Low
  • GGT $4.32
  • STXS $1.54
  • 52 Week High
  • GGT $7.00
  • STXS $2.72
  • Technical
  • Relative Strength Index (RSI)
  • GGT 34.59
  • STXS 63.79
  • Support Level
  • GGT $4.43
  • STXS $1.93
  • Resistance Level
  • GGT $4.44
  • STXS $2.07
  • Average True Range (ATR)
  • GGT 0.11
  • STXS 0.09
  • MACD
  • GGT -0.02
  • STXS 0.02
  • Stochastic Oscillator
  • GGT 1.02
  • STXS 75.79

About GGT Gabelli Multi-Media Trust Inc. (The)

Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: